GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rize Oncology Inc (XCNQ:RIZE) » Definitions » Dividend-Payout-to-FFO

Rize Oncology (XCNQ:RIZE) Dividend-Payout-to-FFO


View and export this data going back to 2022. Start your Free Trial

What is Rize Oncology Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


Rize Oncology Business Description

Traded in Other Exchanges
N/A
Address
301-1665 Ellis Street, c/o Pushor Mitchell LLP, Kelowna, BC, CAN, X1X 1X1
Rize Oncology Inc is is a pharmaceutical company. The company is engaged in oncology, particularly soft tissue sarcoma, introduced by the recent exclusive licensing of STS-201, delivering small molecule targeting soft tissue sarcoma and other cancers.
Executives
William James Garner 10% Security Holder, Director